A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry
One of the City of London’s most storied buildings will become a gathering point for horology enthusiasts when London Watch Week’s City Edition arrives on 18 November. The Royal Exchange, a venue
More
Foreign-manufactured research-use-only peptides have long posed safety concerns for American patients, and Washington has now moved to address that vulnerability directly. The Department of Health and Human Services issued a formal enforcement
More
A firm generating $2.1 billion in annual revenue, carrying little debt, and backed by nearly a century of institutional prestige should be the definition of untouchable. Weil Gotshal & Manges was all
More
When company insiders spend their own money on shares, it tends to be worth paying attention, especially when the market subsequently hands buyers a discount on that price. That is precisely the
More
The politician who helped draft the manifesto that ruled out EU re-entry has now publicly declared that Britain belongs inside the European Union. Rachel Reeves, writing in the Sunday Times in her
More
A bruising week for technology stocks reached a crescendo on Friday as Intel (INTC) plummeted 30% and the Nasdaq Composite tumbled 2.7%, dragging the broader US market sharply lower. Alphabet’s 12% collapse
More
A federal healthcare programme is racing toward a hard deadline with a lawsuit, a congressional bill, and drugmaker legal motions all threatening to derail it. HRSA’s 340B rebate pilot, designed to reshape
More
Since the start of 2026, the 30-year fixed mortgage rate has surged by 25%, creating pressures that extend well beyond the originators who write home loans. For warehouse lenders, the firms that
More
Associates, counsel, and non-capital partners at the collapsing Weil Gotshal & Manges will receive up to 90 days of salary and benefits if they agree to stay through the wind-down process. Eligible
More
Federal Reserve Chairman Kevin Warsh used Wednesday’s post-meeting press conference to quietly announce institutional changes that will reduce future rate-setting opportunities to as few as six per year. Starting in 2027, one
More